Deep immunosuppression and Epstein-Barr virus (EBV) infection promote the emergence of lymphoproliferative disorders in patients undergoing solid organ transplantation. In the last few years a new herpesvirus, named human herpesvirus-8 (HHV-8), has been identified in Kaposi's sarcoma and primary effusion lymphoma (PEL) developing in AIDS patients. Subsequently, the same viral DNA sequences have been identified in almost all cases of Kaposi's sarcoma emerged outside HIV infection, thus suggesting their possible pathogenetic role in this tumor. Similarly, the association between HHV-8 and PEL also emerged in cases without HIV infection, even though the total number of these patients is still limited. Here, we focus on the emergence of this unusual lymphoma in patients undergoing solid organ transplant and underline once again its association with the HHV-8. Moreover, despite the characteristic local growth of this peculiar type of lymphoma, we demonstrate at the molecular level, an early neoplastic spread to the bone marrow suggesting the need to investigate in more detail the origin of the disease, as well as the molecular mechanisms controlling its systemic dissemination.
Introduction
Post-transplant lymphoproliferative disorders (PTLD) are an emergent complication of organ transplantation occurring in 2% to 10% of transplanted patients. 1 Prolonged immunosuppressive treatment and Epstein-Barr virus (EBV) infection are considered the most important factors for the development of these heterogeneous disorders characterized by a wide spectrum of morphologic patterns and genetic abnormalities. 2 Body cavity-based lymphoma, otherwise termed primary effusion lymphoma (PEL), is an unusual lymphoproliferative disorder predominantly described in patients with advanced AIDS. 3 Several data suggest that this lymphoma represents a distinct entity characterized by serous effusions without evidence of organ or bone marrow infiltration, undetermined immunophenotype, frequent association with EBV, clonal immunoglobulin heavy chain (IgH) rearrangement suggesting B-lymphoid cell origin and absence of c-myc oncogene rearrangement. Moreover, the integration of DNA sequences of Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus-8 (HHV-8) is considered the hallmark of PEL. [3] [4] [5] [6] [7] [8] This lymphoma entity is rarely described in AIDS-unrelated patients. 6, [9] [10] [11] [12] [13] Taking advantage of a new case of PEL occurring in an immunosuppressed heart transplanted patient, we review the few cases of AIDS-unrelated PEL so far reported in the literature and suggest that the association between HHV-8 and PEL can also occur in the context of pharmacological immunosuppression. Moreover, we investigate the peculiar pattern of growth in vivo and the in vitro sensibility to anthracycline of this tumor in order to suggest a possible treatment strategy.
History
A 56-year-old man, positive for anti-HCV antibodies and HCV RNA but without liver dysfunction, underwent cardiac transplantation for dilatative cardiomyopathy in July 1994. After surgery the immunosuppression consisted of cyclosporine and azathioprine administration and bolus of steroid to treat episodes of myocardial rejection during the first 2 post-operative months. He remained in a satisfactory condition for 42 months. On February 1998, he was hospitalized for marked astenia and ascites. On admission, physical examination and echographic scan of the abdomen revealed a relevant peritoneal effusion without liver and spleen enlargement. Laboratory data disclosed: white cell count 11700/l, with 91% neutrophils, 4% lymphocytes and 5% monocytes; platelets were 380 000/l and the hemoglobin 13.8 g/dl. Despite a normal liver function, the patient was positive for the anti-HCV antibodies and HCV RNA. Virological tests for B hepatitis and human immunodeficiency virus (HIV) were negative. A modest increase of creatinine level (2.6 mg/dl) was documented. Cytological examination of peritoneal effusion showed a picture consistent with the diagnosis of lymphoma. A total body CT scan failed to demonstrate lymph node enlargement or extranodal masses; a bone marrow biopsy showed no evidence of lymphoma infiltration. Repeated paracentheses were necessary to minimize the ascites. After reduction of cyclosporine dosage and discontinuation of azathioprine, the need for additional paracentheses was reduced, but the poor performance status of the patient discouraged the use of chemotherapy. One month later, the patient developed a progressive renal failure and died at home.
Materials and methods

Cells and tissue processing
Lymphomatous cells were obtained by centrifugation of the peritoneal effusion and used for morphologic evaluation, immunophenotype, cell culture and molecular analysis. For the morphologic diagnosis, the cytospin preparations were routinely stained with May-Grü nwald-Giemsa and observed under light microscopy. Bone marrow aspiration and biopsy obtained at diagnosis were treated according to standard pro-
Figure 1
Morphology of PEL. Air-dried May-Grü nwald-Giemsa stained cytocentrifuge smears of effusion demonstrate a heterogeneous population of medium and large-sized tumor cells characterized by convoluted nuclei and abundant basophilic cytoplasm. Nucleoli were large, irregular in shape and often multiple. A very large number of cells were multinucleated and mitotic figures were common (original magnification, ×400).
tocols for the morphologic evaluation. The bone marrow sample was also separated on Ficoll-Hypaque (Pharmacia, Uppsala Sweden) and the derived mononuclear cells stored at −20°C until DNA extraction was performed.
Immunophenotype
The immunophenotype was performed by flow cytometry on fresh tumor cells or by staining of cytospin preparations. 16 DN-90 (a Burkitt's lymphoma) and ALL-PO (a t(4;11) positive ALL). 17 Briefly, for the flow cytometry assay, we used the following monoclonal antibodies: anti-CD45, CD13, CD33, CD3, CD5, CD7, CD19, CD20, CD10, CD34, HLA-DR, CD38, CD56 (Becton Dickinson, San Jose, CA, USA) and anti-CD138 (Immuno Quality Products, Groningen, The Netherlands) and the FACScan analyzer (Becton Dickinson). The immunoglobulin light chain expression was evaluated both into the cytoplasm by staining of cytospin and on the cell surface by flow cytometry using the FITC-conjugated F(abЈ) 2 fragment of rabbit anti-human lambda light chains (DAKO, Glostrup, Denmark). The expression of the CD30 antigen (Neo Markers, Fremont, CA, USA) was detected on cytospin preparations using the alkaline phosphatase antialkaline phosphatase (APAAP) method. Flow cytometry was also used to test the tumor cell expression of the P-glycoprotein (PGP) and the lung resistance-related protein (LRP) following staining with the MRK-16 MoAb (Kamiya Biomedical, Tukwila, WA, USA) recognizing an external epitope of P170 PGP and the LRP-56 MoAb (Kamiya Biomedical) recognizing the intracellular LRP.
14 The T-lymphoblastic CEM cell line and its sub-line CEM-VBL (courtesy of Dr L Capolongo, Centro Ricerche Pharmacia, Nerviano, Italy) were used as negative and positive control, respectively.
Karyotyping
Karyotype was performed according to standard methods of G-banded chromosome preparations on cells cultured for 48 h with and without mitogens. 
Molecular findings
High molecular weight DNA extracted from peritoneal cells was digested with appropriate restriction enzymes, size-fractionated and blotted according to standard protocol of Southern blotting. 16 Filters were hybridized with appropriate labeled probes to test the EBV genome integration as well as the rearrangement of IgH, c-myc and ALL-1 genes as previously described. 16 ,17 BCL-6 gene rearrangement was evaluated using the specific Sac 4.0 probe 18 (kindly provided by Riccardo Dalla-Favera, MD Columbia University, New York, USA). PCR were performed using 1 g of DNA, the ampliTaq (Perkin Elmer Cetus, Norwalk, CT, USA) and a Perkin Elmer Cetus thermal cycler 9600. The amplification of the 233 bp fragment of the HHV-8 DNA sequence was performed according to the standard protocol described by Cesarman et al. 4 PCR products were run on to a 2% agarose gel for visualization by ethidium bromide, blotted on to nylon membrane and hybridized using a specific probe, internal to HHV-8 PCR product, labeled with ␥-32 P. 4 The same PCR protocol was also used to test 12 specimens of PTLD from heart-transplanted patients referred to our institution in the last 5 years. The definition of the EBV strain was achieved by the amplification of the EBNA-3C gene according to Sample et al. 19 The eventual deletion of the LMP-1 gene of the EBV was tested using the primer pair 9/11 according to Knecht et al. 20 Bcl-2/IgH translocation was evaluated by PCR according to Gribben et al. 21 Finally, the amplification of the CDRIII of the IgH rearrangement, as well as the cloning and sequencing of the PCR product were obtained as previously described. 22 A specific probe spanning the N region of the DJ junction was synthesized, labeled with ␥-32 P and used to hybridize the PCR products of the CDRIII amplification of the PEL and patient's bone marrow mononuclear cells. 22 Cell culture experiments PEL cells, as well as the CEM and CEM-VBL control cell lines, resuspended (1 × 10 6 /ml) in RPMI 1640 (GIBCO, Grand Island, NY, USA) supplemented with fetal calf serum (GIBCO) 10%, were incubated in humidified 5% CO 2 at 37°C with different concentrations of daunorubicin (DNR) (Pharmacia-Farmitalia, Milan, Italy) (100, 200 and 400 ng/ml) or idarubicin (IDA) (Pharmacia-Farmitalia) (50 and 100 ng/ml). Intracellular drug uptake was evaluated by flow cytometry after 30 min of incubation and 24 h later, after washing and resuspension in fresh medium. 23 
Results
Microscopic examination of the cytospin preparations showed a polymorphic population of medium and large-sized tumor cells characterized by convoluted nuclei and abundant basophilic cytoplasm. Nucleoli were large, irregular in shape and often multiple. A very large number of cells were multinucleated and mitotic figures were common (Figure 1) . Flow cytometry showed the following immunophenotype: CD45 + , HLA-DR + , CD38
− . CD30 antigen positive expression into the cytoplasm was determined by immunocytochemistry. Ig expression ( and chains) was found negative both within the cytoplasm and on the cell surface. The karyotype showed abnormalities in
Figure 3
Molecular detection of KSHV DNA integration and tumor cells infiltration within patient's bone marrow. PCR analysis of KSHV DNA sequences was performed using the KS330 233 primers. 4 As negative control a sample containing all PCR reagents without DNA was amplified (lane 1), in parallel with DNA extracted from the AML cell line GF-D8 16 investigate the association between HHV-8 infection and this particular type of non-Hodgkin's lymphoma, PCR analysis was performed by the use of KS330 233 primers derived from KSHV DNA sequence and PCR products were visualized either by ethidium bromide as well as by hybridization using a specific ␥-32 P ATP-labeled probe. 4 As shown in Figure 3 (panels a and b) the expected 233 bp HHV-8 fragment was detected in both PEL cells and bone marrow-derived mononuclear cells obtained from patient at diagnosis. To evaluate the presence of clonal lymphomatous cells in the bone marrow, a patient lymphoma-specific probe was obtained by PCR amplification of the CDRIII region which allowed identification of the junctional-specific sequence. As shown in Figure 3 (panel c) the hybridization with a tumor-specific probe spanning the N region of the DJ junction, allowed demonstration of the fact that PEL cells were also infiltrating the patient's bone marrow at the time of diagnosis. To evaluate the amount of lymphomatous infiltration of the bone marrow a dot blot experiment was run in parallel with PEL DNA serially diluted in DNA derived from normal mononuclear cells. As shown in Figure  3 (panel d) the hybridization signal of the DNA amplified from the patient's bone marrow suggests a neoplastic infiltration of one cell in about 1000. Since a previous paper reported a poor response to chemotherapy as well as a bad clinical outcome of PEL, 25 we searched for laboratory evidence of multidrug resistance in this case of PEL. Indeed, malignant cells obtained from peritoneal effusion expressed both PGP (30%) and LRP (66%) (Figure 4, panels a and b) . Moreover, a functional evaluation of intracellular drug accumulation showed that despite a rapid intake of DNR observed after a short period of incubation (400 ng/ml for 30 min) (Figure 4, panel c) , PEL cells following 24 h of incubation eliminated more that 50% of the previously uptaken drug (Figure 4, panel d) . A similar behavior was found in the multidrug resistance CEM- VBL suclone (Figure 4 , panels e and f), but not in the parental cell line (Figure 4 , panels g and h).
Discussion
PTLD represent a spectrum of EBV-driven lymphoid proliferations ranging from a localized to a diffuse and rapidly progressive disease. These proliferations may arise as polyclonal expansions of EBV-infected B cells, progress to monoclonal B cell lymphoma and sometime regress after reduction of immunosuppressive treatment. 1, 2 We report a new case of a HHV-8+ PEL occurring in an immunosuppressed patient following heart transplantation. The clinical presentation of this lymphoma, the immunophenotype, complex karyotypic abnormalities and molecular data including clonal rearrangement of IgH, absence of c-myc translocation, as well as the integration of HHV-8 DNA sequence are consistent with the characteristics commonly described in PEL developing in AIDS patients. [3] [4] [5] [6] [7] [8] This new lymphoma entity is very uncommon in AIDS-unrelated patients 6,9-13 and the HHV-8 DNA sequence integration seems to be the most important pathogenetic factor shared by these cases (Table 1 ). In the context of solid organ transplanted patients, previous results demonstrate that Kaposi's sarcoma developing in these patients integrate the HHV-8 DNA sequence as observed in Kaposi's sarcoma emerging in AIDS-related patients. 26, 27 Similarly, the case of PEL recently described by Jones et al, 13 as well as the patient described here, underline the key pathogenetic role of HHV-8 in PEL developing in the context of pharmacological immunosuppression. Moreover, this strict linkage was also supported by the constant negativity of HHV-8 DNA integration in all specimens of 12 patients with PTLD referred to our institution during the last 5 years (data not shown).
Neoplastic cells of PEL are confined in vivo along the serous membranes without an invasive growth pattern 7 and this peculiar growth may be related to the interaction between extracellular matrix and the CD138/syndecan-1 antigen expressed by PEL cells. 8 However, the recent establishment of a HHV-8-positive cell line from the peripheral blood of a PEL patient suggests the circulation of neoplastic cells. 28 In our patient, using a tumor-specific probe, we provide evidence that neoplastic cells were localized in the bone marrow at diagnosis. The identification of HHV-8 DNA sequence integration in bone marrow-derived mononuclear cells could be ascribed to the same neoplastic cells even though evidence in multiple myeloma patients seems to localize the HHV-8 into stromal dendritic cells. 29 The poor clinical outcome of PEL in AIDS-related patients is commonly ascribed to the on-going immunosuppressive state of patients, which limits the applicability of potentially curative intensive chemotherapy programs. 25 However, many biologic characteristics of tumor cells influence the efficacy of treatment and in the last years particular attention has been dedicated to mechanisms associated with multidrug resistance.
23, 30 We demonstrate in PEL cells both the expression of PGP and LRP as well as functional evidence of multidrug resistance when cells were exposed to pharmacological doses of different anthracyclines.
This case report highlights the peculiar pathologic and clinical findings associated with secondary malignancies arising in patients undergoing long-lasting immunosuppressive treatment for solid organ transplant. PEL could be added to the clinical spectrum of PTLD and HHV-8 should be considered a new microbiologic agent responsible for the emergence of secondary malignancies in transplanted patients. The epidemiologic correlations between organ transplant, immunosuppressive treatment and HHV-8 infection is a matter of investigation. The prevalence of subjects carrying antibodies to HHV-8 antigens has been estimated between 0% and 8% among normal individuals 31, 32 and 18% among patients undergoing kidney transplantation, in which the allograft has been proposed as a possible vehicle of the viral infection. 31 On the other hand, reactivation of primary HHV-8 infection in transplanted patients was also described. 33 The biologic and molecular mechanisms leading to neoplastic transformation and growth of this peculiar lymphoma require further investigation and cell line models will be invaluable tools for both in vitro and in vivo studies. 34 Despite the apparently local growth of primary effusion lymphomas, our investigation demonstrates the early neoplastic spread to the bone marrow suggesting that the treatment of this peculiar lymphoma would be necessarily systemic. On the other hand, the role of multidrug resistance requires more extensive studies but its association with the proven toxicity of chemotherapy programs in immunocompromised patients, underlines the urgent need to explore different treatment modalities, such as the use of new antiviral drugs capable of inhibiting the virus replication 35 and new biological response modifiers.
